Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alector Inc (ALEC)

Alector Inc (ALEC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alector Inc 131 OYSTER POINT BLVD. SUITE 600 SOUTH SAN FRANCISCO CA 94080 USA

www.alector.com Employees: 238 P: 415-231-5660

Sector:

Medical

Description:

Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 200,838
Enterprise Value, $K 177,208
Shares Outstanding, K 109,151
Annual Sales, $ 100,560 K
Annual Net Income, $ -119,050 K
Last Quarter Sales, $ 3,260 K
Last Quarter Net Income, $ -34,670 K
EBIT, $ -123,700 K
EBITDA, $ -129,240 K
60-Month Beta 0.61
% of Insider Shareholders 9.70%
% of Institutional Shareholders 85.83%
Float, K 98,563
% Float 90.30%
Short Interest 6,320
Short Float 5.79%
Short Volume Ratio 0.53

Growth:

1-Year Return 7.26%
3-Year Return -77.14%
5-Year Return -88.43%
5-Year Revenue Growth 373.89%
5-Year Earnings Growth 28.07%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 11/06/25
Next Earnings Date 02/25/26
Earnings Per Share ttm -1.07
EPS Growth vs. Prev Qtr -13.33%
EPS Growth vs. Prev Year 20.93%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ALEC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -123.02%
Return-on-Assets % -27.48%
Profit Margin % -118.39%
Debt/Equity 0.17
Price/Sales 2.79
Price/Cash Flow N/A
Price/Book 3.26
Book Value/Share 0.57
Interest Coverage -0.99
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar